Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2003
09/11/2003US20030170643 Regulation of apoB treatment and drug screening for cardiovascular and metabolic disorders or syndromes
09/11/2003US20030170632 IL-1 receptor accessory protein
09/11/2003US20030170630 Proteins and nucleic acids encoding same
09/11/2003US20030170628 Forsenic analysis; medical diagnosis; chromosome markers
09/11/2003US20030170627 cDNAs co-expressed with placental steroid synthesis genes
09/11/2003US20030170626 Monitoring gene for inducting immunological response
09/11/2003US20030170621 Polypeptide which modulate cellular response
09/11/2003US20030170620 Gene controlling androgen
09/11/2003US20030170619 Nucleic acid capable of promoting gene expression
09/11/2003US20030170616 Diagnosis using antibodies; genetic engineering
09/11/2003US20030170615 Analyzing using monoclonal antibodies
09/11/2003US20030170614 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
09/11/2003US20030170276 Modified msbB gene
09/11/2003US20030170274 Activation of HCV-specific T cells
09/11/2003US20030170272 EIA vaccine and diagnostic
09/11/2003US20030170271 Chimeric papillomavirus-like particles
09/11/2003US20030170270 Nucleic acid encoding an infectious, nonpathogenic PCV1, which contains an immunogenic open reading frame gene of a pathogenic PCV2 in place of an ORF gene of the PCV1 nucleic acid molecule.
09/11/2003US20030170263 Expression system
09/11/2003US20030170262 Immunogenic detoxified mutant E. coli LT-A toxin
09/11/2003US20030170261 From Neisseria meningitidis; attenuated microorganismsthat have a reduced ability to take up DNA; vaccines
09/11/2003US20030170260 Binds antibodies specific for Rhodococcus equi and the VapA protein.
09/11/2003US20030170259 Chlamydia antigens and corresponding dna fragments and uses thereof
09/11/2003US20030170257 Protecting animals against the bite of blood-sucking ectoparasites and against the transmission of viruses, bacteria and other pathogens by such ectoparasites.
09/11/2003US20030170256 Coding for antigens expressed by tumor cells which may be recognized by cytotoxic T cells, leading to lysis of the tumor that express it.
09/11/2003US20030170255 Compositions and methods for the therapy and diagnosis of lung cancer
09/11/2003US20030170254 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/11/2003US20030170253 Useful in stimulating angiogenesis as well as in diagnostic applications.
09/11/2003US20030170246 Fusion protein, comprising a first lipophilin-like polypeptide linked by a peptide bond to a second lipophilin-like polypeptide; polynucleotides encoding the protein; antibodies; especially for breast, ovarian or prostate cancer.
09/11/2003US20030170242 Novel isoforms of vascular endothelial cell growth inhibitor
09/11/2003US20030170240 Composition of an endogenous insulin-like growth factor-II derivative
09/11/2003US20030170237 G-CSF receptor agonist antibodies and screening method therefor
09/11/2003US20030170230 Use of the AHEC region permits the assembly of antibody fragments into defined multimeric complexes
09/11/2003US20030170229 Epitopes or mimotopes derived from the C epsilon 3 or C epsilon 4 domains of IgE; prevention or amelioration of allergic disease.
09/11/2003US20030170228 Compositions and methods for the treatment of tumor
09/11/2003US20030170222 For therapy of cancer; for therapy of disorders associated with voltage-gated ion channels, ligand gated channels and other receptors
09/11/2003US20030170220 For inhibiting growth of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, or benign prostate hyperplasia
09/11/2003US20030170208 To promote osteogenesis and therefore uses include fracture healing and repair and acceleration of fracture healing
09/11/2003US20030170206 Interferon beta-like molecules
09/11/2003US20030170205 For modulating the proliferation, differentiation, migration, or metabolism of mesencymal cells in an animal
09/11/2003US20030170203 Death domain containing receptors
09/11/2003US20030167999 Crystal
09/10/2003EP1342795A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/10/2003EP1342785A1 Gene hd3a inducing flowering of plant and utilization thereof
09/10/2003EP1342784A1 ExPEC-specific proteins, genes encoding them and uses thereof
09/10/2003EP1342783A1 An active VEGF being resistant to proteolysis
09/10/2003EP1342781A1 Recombinase fusion protein with enhanced cellular uptake
09/10/2003EP1342779A1 Means and methods for manipulating hypersensitivity-like responses
09/10/2003EP1342730A1 Fusion protein having the enhanced in vivo activity of erythropoietin
09/10/2003EP1342729A2 Antibodies and antisense molecules for G-coupled receptor showing selective affinity for ATP
09/10/2003EP1342728A1 Radiosensitivity enhancers in radiotherapy for cancer and nucleic acids and proteins enhancing radiosensitivity
09/10/2003EP1342727A1 Antibody against norwalk virus and method of detecting virus by using the antibody
09/10/2003EP1342476A2 FGFR3 as a marker for mesenchymal skeletal progenitor cells and use of cytotoxic conjugates comprising an FGFR3 binding agent for the treatment of cartilagineous bony tumours
09/10/2003EP1342410A2 Transgenic animals lacking a functional galanin gene
09/10/2003EP1342085A2 Non-apoptotic forms of cell death and methods of modulation
09/10/2003EP1342084A2 Assay for anti-viral agent
09/10/2003EP1342063A1 Assay for paralytic shellfish toxin
09/10/2003EP1341930A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human adult liver
09/10/2003EP1341915A1 Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue
09/10/2003EP1341914A2 Regulation of angiogenesis with zinc finger proteins
09/10/2003EP1341913A2 Socs (suppressor of cytokine signaling)
09/10/2003EP1341912A2 Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains
09/10/2003EP1341899A2 Bacterial host strains
09/10/2003EP1341820A2 Monoclonal antibodies to human immunodeficiency virus and uses thereof
09/10/2003EP1341819A2 Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament
09/10/2003EP1341818A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/10/2003EP1341817A2 Tff peptides
09/10/2003EP1341816A2 Peptides derived from colostrinin
09/10/2003EP1341815A2 Compositions and methods related to the minn1 tumor suppressor gene and protein
09/10/2003EP1341814A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/10/2003EP1341813A1 Use of l-carnitine as stabilizing agent of proteins
09/10/2003EP1341812A2 Secreted proteins
09/10/2003EP1341811A2 Orally ingestible preparation of mistletoe lectins and method
09/10/2003EP1341810A2 Secreted chlamydia polypeptides and method for identifying such polypeptides by their secretion by a type iii secretion pathway of a gram-negative bacteria.
09/10/2003EP1341809A2 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test
09/10/2003EP1341807A2 Interferon-alpha induced gene
09/10/2003EP1341804A2 Novel nucleic acids and polypeptides
09/10/2003EP1341803A2 Novel nucleic acids and polypeptides
09/10/2003EP1341558A2 A novel system for the evaluation of the activity and/or specificity of a viral component
09/10/2003EP1272845A4 SOLUTION AND CRYSTAL STRUCTURES OF ZipA AND ZipA COMPLEX AND USES THEREOF
09/10/2003EP1179012B9 Long lasting fusion peptide inhibitors of viral infection
09/10/2003EP1091948B9 Tubulin binding compounds (cobra)
09/10/2003EP1075540B1 Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
09/10/2003EP1054689B1 Strategically modified hepatitis b core proteins and their derivatives
09/10/2003EP0966483B1 Beta-endorphin peptides for treating muscle-wasting diseases
09/10/2003EP0939627B1 Pentafluorobenzenesulfonamides and analogs
09/10/2003EP0914613B1 Dp and e2f protein nuclear localisation signals and their use
09/10/2003EP0906122B1 Activated linkers and methods for making and purifying the same
09/10/2003EP0871763A4 Method for preparation of type ii collagen
09/10/2003EP0736106B1 Methods of screening for beta-amyloid peptide production inhibitors
09/10/2003EP0689843B1 Composition containing soluble thrombomodulins
09/10/2003EP0654092B1 Method for detecting pre-cancerous or cancerous cells using p90 and p53 antibodies or probes
09/10/2003EP0594732B1 Humanized antibody against cd18
09/10/2003EP0575546B1 Cyclin d1 and its cdna
09/10/2003CN1441843A Extracellular matrix protein
09/10/2003CN1441842A Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof
09/10/2003CN1441811A Anti-body capable to selectively detect prion PrPsc isoforms
09/10/2003CN1441810A Soluble CTL A4 mutant molecules and use thereof
09/10/2003CN1441809A Antifungal and/or antibacterial peptides, preparation methods and composition containing same
09/10/2003CN1441808A Chemokine receptor modulators, production and use
09/10/2003CN1441807A Hepatitis B core antigen fusion proteins
1 ... 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 ... 2916